1. Development and validation of an HPLC–MS/MS method to simultaneously quantify alectinib, crizotinib, erlotinib, gefitinib and osimertinib in human plasma samples, using one assay run. (31st August 2021) Authors: van Veelen, Ard; van Geel, Robin; Schoufs, Roy; de Beer, Yvo; Stolk, Leo M.; Hendriks, Lizza E. L.; Croes, Sander Journal: Biomedical chromatography Issue: Volume 35:Number 12(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Official International Association for Therapeutic Drug Monitoring and Clinical Toxicology Guideline: Development and Validation of Dried Blood Spot–Based Methods for Therapeutic Drug Monitoring. Issue 4 (August 2019) Authors: Capiau, Sara; Veenhof, Herman; Koster, Remco A.; Bergqvist, Yngve; Boettcher, Michael; Halmingh, Otto; Keevil, Brian G.; Koch, Birgit C.P.; Linden, Rafael; Pistos, Constantinos; Stolk, Leo M.; Touw, Daan J.; Stove, Christophe P.; Alffenaar, Jan-Willem C. Journal: Therapeutic drug monitoring Issue: Volume 41:Issue 4(2019:Aug.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Risk of myocardial infarction in patients with atrial fibrillation using vitamin K antagonists, aspirin or direct acting oral anticoagulants. (23rd March 2017) Authors: Stolk, Leo M.; de Vries, Frank; Ebbelaar, Chiel; de Boer, Anthonius; Schalekamp, Tom; Souverein, Patrick; ten Cate‐Hoek, Arina; Burden, Andrea M. Journal: British journal of clinical pharmacology Issue: Volume 83:Number 8(2017) Page Start: 1835 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗